title: Understanding drugs and diseases by systems biology?
abstract: Systems biology aims to provide a holistic and in many cases dynamic picture of biological function and malfunction, in case of disease. Technology developments in the generation of genome-wide datasets and massive improvements in computer power now allow to obtain new insights into complex biological networks and to copy nature by computing these interactions and their kinetics and by generating in silico models of cells, tissues and organs. The expectations are high that systems biology will pave the way to the identification of novel disease genes, to the selection of successful drug candidates--that do not fail in clinical studies due to toxicity or lack of human efficacy--and finally to a more successful discovery of novel therapeutics. However, further research is necessary to fully unleash the potential of systems biology. Within this review we aim to highlight the most important and promising top-down and bottom-up systems biology applications in drug discovery.
authors: Sanofi-Aventis Deutschland GmbH, R&D LGCR/Struct, Design & Informatics FF, Computational Biology & Bioinformatics, 65926 Frankfurt am Main, Germany.
authors: Hans-Christoph
authors: HC
authors: Schneider
authors: Thomas
authors: T
authors: Klabunde
mesh_terms: D000818:Animals; D004194:Disease; D055808:Drug Discovery; D006801:Humans; D049490:Systems Biology